CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-01 | BOLL ANDREW R. Chief Financial Officer | Option exercise | +30,000 | $1.83 | $55K | 84,000 |
| 2018-02-01 | BOLL ANDREW R. Chief Financial Officer | Option exercise · Restricted Stock Unit | −30,000 | 30,000 | ||
| 2018-01-02 | SAHAREK JOHN P. Chief Commercial Officer | Grant or award · Option - Right to Buy | +50,000 | 50,000 | ||
| 2018-01-02 | BAUM MARK L Chief Executive Officer | Grant or award · Option - Right to Buy | +150,000 | 150,000 | ||
| 2018-01-02 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Option - Right to Buy | +50,000 | 50,000 | ||
| 2017-07-17 | Kammer Robert J Director | Sale | −10,000 | $3.05 | $31K | 1,059,827 |
| 2017-06-13 | Principi Anthony Director | Grant or award · RSU | +15,723 | 15,723 | ||
| 2017-06-13 | LINDSTROM RICHARD L MD Director | Grant or award · RSU | +15,723 | 15,723 | ||
| 2017-06-13 | Kammer Robert J Director | Grant or award · RSU | +15,723 | 15,723 | ||
| 2017-06-13 | AUSTIN STEPHEN G Director | Grant or award · RSU | +15,723 | 15,723 | ||
| 2017-04-27 | LINDSTROM RICHARD L MD Director | Option exercise | +100,000 | $1.79 | $179K | 100,000 |
| 2017-04-27 | LINDSTROM RICHARD L MD Director | Gift · Purchase Warrant | −100,000 | 0 | ||
| 2017-04-27 | LINDSTROM RICHARD L MD Director | Gift · Purchase Warrant | +100,000 | 100,000 | ||
| 2017-04-27 | LINDSTROM RICHARD L MD Director | Option exercise · Purchase Warrant | −100,000 | 0 | ||
| 2017-04-13 | Edwards Clayton D Chief Operating Officer | Grant or award · Option - Right to Buy | +55,000 | 55,000 | ||
| 2017-03-09 | Kammer Robert J Director | Other disposition | −20,000 | 1,069,827 | ||
| 2017-02-01 | SAHAREK JOHN P. Chief Commercial Officer | Grant or award · Option - Right to Buy | +55,000 | 55,000 | ||
| 2017-02-01 | BOLL ANDREW R. Chief Financial Officer | Grant or award · Option - Right to Buy | +55,000 | 55,000 | ||
| 2017-02-01 | BAUM MARK L Chief Executive Officer | Grant or award · Option - Right to Buy | +160,000 | 160,000 | ||
| 2016-12-19 | LINDSTROM RICHARD L MD Director | Purchase | +100,000 | $1.79 | $179K | 100,000 |
Page 15 of 17 · 336 trades